Why is a quality assessment on European level important for next generation seuencing (NGS)? What needs to be improved and what’s the benefit of having a network of expert centers like ERN-RND to work with?
Ales Maver, clinical laboratory scientist at the University Medical Center in Ljubljana, talks about the insights and outcomes of the quality assessment for NGS that was done within the ERN-RND network 2024 in this video:
For more Information, see paper:
Quality assurance for next-generation sequencing diagnostics of rare neurological diseases in the European Reference Network.
Aleš Maver, Katja Lohmann, Fran Borovečki, Nicola Wolstenholme, Rachel L. Taylor, Malte Spielmann, Tobias B. Haack, Matthias Gerberding, Borut Peterlin & Holm Graessner